| Date | Title | Description |
| 28.10.2024 | Apple’s Ambitious Leap into Diabetes Monitoring: A Game Changer on Your Wrist | Apple is on the brink of a health revolution. Imagine a world where your watch not only tells time but also keeps tabs on your blood sugar levels. This isn’t science fiction; it’s the future Apple is crafting. The tech giant is testing a gr... |
| 28.10.2024 | Apple’s big ambitions in health care | Image: Dall-E
Apple, seeking to make further inroads in health care, tested an app this year to help people with pre-diabetes manage their food intake and make lifestyle changes, according to people with knowledge of the matter.
The company... |
| 26.10.2024 | Future Apple Watches could tell you if you’re at risk for diabetes | An apple a day might keep the doctor away, but an Apple device on your wrist could replace them altogether. Well, sort of. The Apple Watch is already chock-full of health-focused applications, but according to a recent report from Mark Gurm... |
| 26.10.2024 | Apple тестирует приложение для контроля уровня сахара в крови | Apple тестирует приложение, которое позволит проверять уровень сахара в крови неинвазивным способом.
Устройство неинвазивного мониторинга глюкозы от Dexcom
Приложение уже опробовали сотрудники компании с преддиабетным состоянием. Параллельн... |
| 14.09.2024 | Производитель умного кольца Oura приобрел стартап в области метаболического здравоохранения Veri | Согласно недавнему заявлению в FCC, старт продаж Oura Ring 4 может произойти со дня на день, сообщает TechCrunch. Тем временем у производителя медицинского оборудования есть еще одна значимая новость. В среду компания Oura объявила о приобр... |
| 14.09.2024 | DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit | NEW YORK, Sept. 14, 2024 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between January 8, 2024 and July 25, 2024, both dates inclusive (the "Clas... |
| 11.09.2024 | U.S. and European Patient Monitoring Equipment Market Update: Remote Patient Monitoring, IoT, ASCs, and the Rapid EEG Market | iData Research | VANCOUVER, BC, Sept. 11, 2024 /PRNewswire/ - iData Research, a leading global consulting and market research firm, has released new, in-depth reports on the U.S. and European patient monitoring equipment (PME) markets. The reports highlight... |
| 06.09.2024 | DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit | NEW YORK, Sept. 6, 2024 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of all purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between January 8, 2024 ... |
| 05.09.2024 | Dexcom's New Glucose Monitor: A Double-Edged Sword for Investors and Consumers | Dexcom has stepped into the spotlight with its latest product, Stelo, a continuous glucose monitor (CGM) now available over-the-counter. This move is a bold attempt to broaden its market reach beyond diabetes patients. The company aims to t... |
| 05.09.2024 | Type 1 diabetes patients welcome subsidies for glucose monitoring system, but call for more support | Listen to this article
Type 1 diabetes patients welcome subsidies for glucose monitoring system, but call for more support
1 min
New: You can now listen to articles.
This audio is generated by an AI tool.
SINGAPORE: At three years old, Maso... |
| 03.09.2024 | Health | Dexcom starts selling its new over-the-counter glucose monitor. Here’s how much it costs | Dexcom said the use of its continuous glucose monitors on its own or alongside other diabetes or weight management tools can help people understand how different foods or activities affect their glucose levels.
When Dexcom announced the rol... |
| 30.08.2024 | DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit | NEW YORK, Aug. 30, 2024 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of all purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between January 8, 2024 ... |
| 28.08.2024 | DexCom's Stelo: A Game Changer for Glucose Monitoring | In a world where health is paramount, DexCom has stepped into the spotlight. The company recently launched Stelo, the first over-the-counter glucose biosensor in the United States. This innovation is a beacon of hope for millions grappling ... |
| 26.08.2024 | DexCom launches Stelo, first over-the-counter glucose biosensor in U.S., available without prescription | DexCom, a maker of real-time continuous glucose monitoring devices, announced today the availability of Stelo, the first over-the-counter glucose biosensor in the U.S., now purchasable without a prescription at Stelo.com. This new offering ... |
| 26.08.2024 | DexCom Launches Non-Prescription Glucose Biosensor in U.S. | What You Should Know:
– Millions of Americans with Type 2 diabetes and prediabetes now have a new option for managing their glucose levels.
– DexCom, a leader in continuous glucose monitoring (CGM) technology announced the launch of Stelo, ... |
| 23.08.2024 | DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit | NEW YORK, Aug. 23, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between January 8, 2024 an... |
| 08.08.2024 | Fierce Competition and Technological Innovation Drive Diabetes Care Devices Market Towards Explosive Growth | OEMs Leading the Charge with AI-Equipped Technology and Novel Business Strategies
SAN ANTONIO, Aug. 8, 2024 /PRNewswire/ -- The diabetes care devices industry is witnessing a dynamic evolution, marked by intense competition among establishe... |
| 27.07.2024 | Wall St closes up on revival supported by inflation data, tech stocks | U.S. MarketsWall St closes up on revival supported by inflation data, tech stocks
By David FrenchJuly 26, 202411:31 PM UTCUpdated ago
Text
Small Text
Medium Text
Large Text
Share
X
Facebook
Linkedin
Email
Link
SummaryCompanies
PCE inflation... |
| 21.06.2024 | Locus Health Announces New Integration in Diabetes Health with Dexcom | Locus Logo
Locus’ integration with Dexcom will allow for multiple populations using CGM to integrate their care directly with their healthcare systems EHR.
Glucose is the next vital sign... CGMs have a significant role in patient health, an... |
| 10.06.2024 | Olympic athletes turn to diabetes tech in pursuit of medals | :Olympians including Dutch marathon runner Abdi Nageeye are using a new tool they hope will boost their medal chances this summer: tiny monitors that attach to the skin to track blood glucose levels.
Continuous glucose monitors or CGMs were... |
| 05.06.2024 | Dexcom G7 continuous glucose monitoring system now connects directly to Apple Watch | DexCom has announced that its Dexcom G7 Continuous Glucose Monitoring (CGM) System now connects directly to Apple Watch in the United States. The Dexcom G7 is the first and only CGM system offering real-time glucose readings on the Apple Wa... |
| 22.05.2024 | Nick Jonas shares his top 3 self-care strategies, including one he "used to overlook" | Nick Jonas is a "Sucker" for self-care.
The singer and actor, 31, has a few go-to's when it comes to taking care of his mental health as part of his diabetes management.
"There is that mental health effect that that comes int... |
| 20.05.2024 |
Dexcom launches new sensor in the UK | The ONE+ system, featuring a sensor, reader, smartphone, smartwatch and applicator. [Image courtesy of Dexcom]Dexcom (Nasdaq: DXCM) + announced today that it launched the Dexcom ONE+ continuous glucose monitor (CGM) in the UK.
ONE+ uses Dex... |
| 17.05.2024 | Revolutionizing Obesity Treatment with Precision Medicine | Phenomix Sciences, a cutting-edge biotechnology company, has secured a whopping $7.8 million in funding to accelerate the adoption of precision medicine in the treatment of obesity. This influx of capital, including $5.5 million in Series A... |
| 16.05.2024 | Phenomix Sciences Raises $7.8M to Acclerate Obesity Precision Medicine Adoption | What You Should Know:
– Phenomix Sciences (Phenomix), a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, has secured $5.5 million in Series A funding from new investors, DexCom, Inc. and La... |
| 12.03.2024 | Global Continuous Glucose Monitoring (CGM) Devices Market Report 2024-2030 - Sensors Lead Revenue Share, Bluetooth Connectivity Surges, Homecare Segment Accelerates Growth, North America Dominates | - |
| 04.03.2024 | mHealth Market to Surpass USD 70.7 billion by 2032, exhibiting a CAGR of 18% | mhealth Market AMR
PORTLAND, OR, UNITED STATE, March 4, 2024 /EINPresswire.com/ -- The analysts at Allied Market Research have introduced a fresh research study titled "mHealth Market: Global Outlook and Forecast 2023-2032." This ... |
| 14.01.2024 | The best products and ideas at CES 2024 | The DeanBeat | Do you want to get the latest gaming industry news straight to your inbox? Sign up for our daily and weekly newsletters here.
The CES 2023 tech trade show is finally over in Las Vegas, after a grueling six days for me and crowds that number... |
| 24.07.2023 | Revolutionizing Diabetes Management: Dexcom, Andesfit, Veyetals and SenSights.AI Team Up for Advanced Glucose Monitoring | Dexcom CGM integration with SenSights.AI RPM
SenSights.AI integrates FDA-approved Andesfit and Dexcom's CGM, along with Veyetals into its comprehensive RPM Platform for streamlined glucose monitoring
We are the only RPM vendor offering all ... |
| 22.06.2023 | Rimidi Showcases Addition of Glycemic Risk Index to Diabetes Management Platform, Announces Enhanced Integration with Dexcom | GRI is an exciting new tool in the toolkit for clinicians and Rimidi is committed to bringing this innovation into the clinical workflow.
ATLANTA (PRWEB) June 22, 2023
Rimidi, a leading clinical management platform designed to optimize clin... |
| 13.02.2023 | Dexcom G7 Continuous Glucose Monitoring System Will Be Available to Medicare Beneficiaries at Launch | Dexcom, the global leader in real-time continuous glucose monitoring for people with diabetes, announced its next-generation Dexcom G7 CGM System will be covered for Medicare beneficiaries.† Having met the category requirements for therapeu... |
| 24.01.2023 | Dexcom Ventures Invests in MedCrypt’s Medical Device Cybersecurity Platform | What You Should Know:
The global wearable medical device market size is currently valued at $21.3 billion and is expected to grow 28% by 2030. Cybersecurity remains one of the biggest hurdles for connected devices across all areas of health... |
| 02.12.2022 | DTC Metabolic Tracker Company To Expand Personalized Nutrition Guidance With $62M | Users breathe into the Lumen device in order to get a reading on their metabolism. Based on the results, the connected app will give users a recommendation to follow a low-carb diet that day, a high-carb diet or somewhere in-between.
Wellne... |
| 12.08.2022 | Dexcom Receives FDA Clearance for G7 Continuous Glucose Monitoring (CGM) System | What You Should Know: |
| 08.08.2022 | OTC: ILUS, ILUS International (Ilustrato Pictures International Inc.) Confirms the Settlement of Two $500,000 Notes and Announces a Further $5.6 Million in Funding | NEW YORK, NY, Aug. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- ILUS International Inc. (OTC: ILUS) is a Mergers and Acquisitions company focused on acquiring and developing public safety technology-based companies across the globe. The... |
| 10.05.2022 | Dexcom G7 Blood Glucose Monitoring Launches in 5 Global Markets | What You Should Know:
New features with Dexcom G7 include:
– 60 percent smaller, all-in-one, discreet wearable, developed in partnership with Verily
– 30-minute sensor warm up, fastest of any CGM on the market*
– 12-hour grace period to rep... |
| 07.03.2022 | These 10 medtech companies’ stocks performed best in 2021 | (From Ishant Mishra on Unsplash)
Following a year like no other in 2020, 2021 was when many looked to rebound — including the medtech industry.
A number of medtech companies followed up a challenging, pandemic-enveloped year with impressive... |
| 24.01.2022 | MERCER INTERNATIONAL INC. ANNOUNCES COMPLETION OF CDN$160 MILLION REVOLVING CREDIT FACILITY | NEW YORK, NY - Mercer International Inc., or 'Mercer', (Nasdaq: MERC) announced that certain Canadian subsidiaries (the 'Loan Parties') of Mercer have entered into a new CDN$160 million joint asset-backed revolving credit facility (the 'New... |
| 22.01.2022 | Mercer International Inc. Announces Completion of CDN$160 Million Revolving Credit Facility | NEW YORK, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Mercer International Inc., or "Mercer", (Nasdaq: MERC) today announced that certain Canadian subsidiaries (the "Loan Parties") of Mercer have entered into a new CDN$160 million... |
| 22.01.2022 | Mercer International Inc. Announces Completion of CAD 160 Million Revolving Credit Facility | Mercer International Inc. announced that certain Canadian subsidiaries (the "Loan Parties") of Mercer have entered into a new CAD 160 million joint asset-backed revolving credit facility (the "New Facility") with a syndi... |
| 21.01.2022 | Mercer International Inc. Announces Completion of CDN$160 Million Revolving Credit Facility | NEW YORK, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Mercer International Inc., or "Mercer", (Nasdaq: MERC) today announced that certain Canadian subsidiaries (the "Loan Parties") of Mercer have entered into a new CDN$160 million... |
| 12.01.2022 | Abbott is out to win hearts and minds. Will it one day become a household name? | Rarely do medtech companies have the name recognition that businesses with a closer connection to consumers do. Johnson & Johnson’s name is ubiquitous less for its pure medtech devices than consumer staples like Q-tips, Band-Aids and Ty... |
| 15.12.2021 | Tern : Why invest in IoT stocks? | Crypto may be the tech buzzword of the decade, but IoT is silently eating up market share in investors' pockets. Internet of things (IoT) devices are working their way into every home, warehouse and storeroom at an alarming rate. Help Net S... |
| 10.11.2021 | Signos raises $13M Series A to give you real-time weight-loss advice based on your blood glucose levels | In a world where we count every step and measure every heartbeat, hopping on the scale once per week to keep half an eye on what your body is doing just won’t do. Even if you stand around on the glass oracle of mass a few times per day, the... |
| 28.10.2021 | Dexcom Reports Third Quarter 2021 Financial Results - Form 8-K | Dexcom Reports Third Quarter 2021 Financial Results
SAN DIEGO, CA - (BUSINESS WIRE-October 28, 2021) - DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended September 30, 2021.
Third Quarter 2021 F... |
| 01.10.2021 | OTC: ILUS, ILUS International (Ilustrato Pictures International Inc) Acquisition, BCD Fire, Secures a New Contract Valued at $ 1 Million and Hires 46 New Staff | NEW YORK, NY, Oct. 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – ILUS International Inc (OTC: ILUS), ILUS is a M&A company focussed on acquiring and developing technology-based companies globally. The company has already completed fou... |
| 23.09.2021 | Sopharma Trading : expands its portfolio of exclusive brands | Starting September 2021, Sopharma Trading will be partner on the Bulgarian market of the world-famous manufacturer of sensors for continuous measurement of glucose Dexcom. This partnership combines the innovation and high quality of the Cal... |
| 02.09.2021 | Internet of Medical Things: How Connected Devices are Changing Healthcare | The number of connected medical devices – the ones communicating with other systems via the Internet – is growing steadily. These smart things gather and transmit a mountain of healthcare data. Even such small gadgets as fitness trackers an... |
| 11.08.2021 | OTC: ILUS, ILUS International (Ilustrato Pictures International Inc) Acquisition BCD Fire Secures Three New Contracts in the Third Quarter of 2021, Valued at Over $1.5 Million | NEW YORK, NY, Aug. 11, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- ILUS International Inc (OTC: ILUS) is a M&A company focused on acquiring and developing technology-based companies globally. The company has already completed three acq... |
| 30.07.2021 | Here’s why a job ad has me excited for the Apple Watch of my dreams | The Apple Watch is the smartwatch to beat, with every player in the industry trying to come up with better alternatives. Many wearables look like an Apple Watch from a distance, but they’re not quite as complex. Apple keeps innovating its w... |
| 28.07.2021 | Haynes International, Inc. announces an Equity Buyback for $20 million worth of its shares. | Haynes International, Inc. (NasdaqGS:HAYN) announces a share repurchase program. Under the program, the company will repurchase up to $20 million worth of its common stock. The company will repurchase its shares from the available cash. The... |
| 30.04.2021 | Dexcom stock takes a tumble, despite reporting increased Q1 revenue | Photo by Kwanchai Lerttanapunyaporn/EyeEm/Getty Images |
| 12.02.2021 |
Dexcom Launches Venture Capital Fund
| San Diego-based Dexcom, which develops equipment for continuous glucose monitoring for people with diabetes, has launched its own venture capital fund, Dexcom Ventures. According to Dexcom, the new fund will seek to identify and invest in o... |
| 17.09.2020 | Making the jump from investor to start-up | Author: Tom MoonThe growth of Current Health in 2020 has been astonishing. At the end of 2019 its market-leading remote care platform was well-placed to support the long-term trend of healthcare moving outside the four walls of the hospital... |
| 31.07.2020 | Dexcom makes controlling blood sugar far simpler for diabetes patients — and everyone else too | If you’ve ever wondered if the data we’re amassing will be useful, check out the continuous glucose monitor from the medical device company Dexcom.
As a tech narcissist, I’ve been interested for years in how technology can deliver a “quanti... |
| 31.07.2020 | Dexcom makes controlling blood sugar far simpler for diabetes patients — and everyone else too | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
If you’ve ever wondered if the data we’re amassin... |
| 07.01.2019 | Dexcom, glowing from fabulous results, dismisses Medtronic as a viable CGM competitor at JPM | Dexcom CEO Kevin Sayer was positively beaming as he stood in front of a large audience gathered to hear his presentation at the annual J.P. Morgan Healthcare Conference in San Francisco on Monday.
Fresh off of pre-announcing fourth quarter ... |
| 25.09.2018 | Dexcom Acquires TypeZero Technologies | Dexcom, Inc., a provider of continuous glucose monitoring solutions for people with diabetes, acquired TypeZero Technologies, a Charlottesville, VA-based inControl Diabetes Management Platform startup.
The amount of the deal was not disclos... |
| 10.08.2018 | Dexcom beats revenue guidance, eyes iCGM G6 sales for next quarter's growth | |
| 25.05.2018 | Dexcom outperforms growth expectations but proceeds with caution | Credit: Dexcom |
| 28.03.2018 | FDA clears new Dexcom CGM that requires no patient calibration earlier than expected | The regulatory nod “comes several months ahead of management’s” guidance, wrote Danielle Antalffy, an equity research analyst with Leerink Partners, a healthcare investment bank, in a research note Tuesday after the announcement was made.
B... |
| 06.10.2017 | ScotSoft 2017: Showcasing Scotland To The World | 20 years is a long time when it comes to digital technology. Hardware, programming languages, business models and whole markets have grown, flourished, withered and died in that time. Yet ScotSoft, Scotland’s longest-running digital confere... |
| 07.09.2017 | Fitbit is teaming up with Dexcom for glucose monitoring on the Ionic Smartwatch | Wearable fitness makers are increasingly interested in tracking our vitals. Now Fitbit has announced a collaboration with glucose monitor company Dexcom to develop and market products to help those with diabetes better manage the disease, s... |
| 24.03.2017 | Dexcom will reap benefit as CMS posts criteria for Medicare coverage of CGMs | DexCom, diabetes professional societies, endocrinologists, the American Diabetes Association and the Juvenile Diabetes Research Foundation (JDRF) have been working on this with CMS for years, according to DexCom CEO Kevin Sayer.
“It does ex... |
| 26.10.2016 | ENGAGE: 5 takeaways from MedCity’s patient engagement conference | Many things stood out for me from this year’s event including the widespread acceptance of the value of engagement, expansion of participants across the healthcare ecosystem, diversity of the speakers and participants, the personalization o... |
| 21.10.2016 | This is what deep patient satisfaction looks like | However, once in a while, you run into a situation that cuts through the hype and goes to the heart of what healthcare innovation is striving for every day: deep patient satisfaction.
And so it was at MedCity’s own ENGAGE conference in San ... |
| 17.10.2016 | Wearable health tech firm Dexcom will redefine what is possible in managing personal healthcare | |
| 07.09.2016 | Pharmaceutics International, Inc. (Pii) Receives $93 Million in Growth Capital | HUNT VALLEY, MARYLAND (September 6, 2016) – Pharmaceutics International, Inc. (“Pii”), a contract development and manufacturing organization (“CDMO”) based in Hunt Valley, MD, announced today that it has entered into a definitive agreement ... |
| 06.09.2016 | Pharmaceutics International, Inc. (Pii) Receives $93 Million In Growth Capital | HUNT VALLEY, MARYLAND, September 6, 2016 /PRNewswire/ -- Pharmaceutics International, Inc. ("Pii"), a contract development and manufacturing organization ("CDMO") based in Hunt Valley, MD, announced today that it has ent... |
| 26.05.2016 | Medtronic allies with Qualcomm Life in quest for continuous glucose monitoring with smaller design, better data | The device bigwig also has diabetes-centric partnership with IBM Watson Health, and has invested in start-ups Dreamed Diabetes and Glooko.
“We believe that glucose should be a vital sign of diabetes health. Professional CGM is an increasing... |
| 13.08.2015 | Why Google and DexCom will change the Type 2 diabetes market | This trifecta could very soon herald very exciting products that would be ripe for a wide market – innocuous blood sugar monitoring system for those with mild diabetes, or an artificial pancreas that’s smart phone enabled for more serious c... |
| 17.04.2015 | Apple Watch apps part 2: Tracking sickness by neighborhood, adjusting hearing aid settings | Beltone a hearing aid manufacturer developed an app called HearPlus to help users personalize their hearing aid settings using their watch. They can set volume control and adjust things like ambient noise.
BACtrack unveiled a version of its... |
| 10.02.2015 | The Apple Watch May Have Its First Medical App—A Glucose Monitor For Diabetics | We already knew that the Apple Watch, due to finally launch in April, will feature fitness applications. Now it may have its first health-related app as well.
Over the weekend, the Wall Street Journal reported that a new Apple Watch app is ... |
| 30.01.2015 | Diabeto wants to add cute factor to blood-glucose monitoring for diabetes | Diabeto has done pretty well with the campaign. After 11 days it has secured $14,984, quite a bit more than its $10,000 goal to raise enough funding to position itself for FDA approval in the U.S.. The funding is also intended to support pr... |
| 27.01.2015 | Dexcom plans to add decision support apps for glucose monitoring platform | The apps were approved through a regulatory pathway for low- to moderate-risk medical devices that are novel and not substantially equivalent to any legally marketed device, according to a Dexcom statement.
CEO Kevin Sayer said he expected ... |
| 23.01.2015 | Dexcom marks new milestone with FDA approval of continuous glucose monitoring apps to share data | Two Dexcom Share System apps display data from its G4 Platinum CGM System, which gets blood glucose readings from a needle with a senor inserted just under the skin of the person being monitored. One app is installed on the patient’s mobile... |
| 07.01.2015 | CES 2015: Dexcom G4 Platinum CGM (Continuous Glucose Meter) Makes Living With Diabetes Easier | James Geddes, Tech Times 07 January 2015, 11:01 pm
Tech Times announced our 2015 CES Best of Innovation Honorees and the list of winners included everything from Samsung's ultra-thin and powerful Series 9 2015 Edition Ultrabook to LG's 4K U... |
| 29.08.2014 | Medical device patent law: Changes, subtleties and tricks-of-the-trade secrets | From a practical standpoint, if you can’t file as quickly as possible, what’s the key? Before public disclosure. Now, if you’re giving a quick speech at a conference somewhere, for example, and at the 3:15 mark you disclose something, that’... |
| 13.06.2014 | Joslin executive director: Mobile health apps are the future | “We see that the future is with mobile apps. They will boost efficient reporting and make physicians more efficient.” Still, these tools pose their own sets of challenges.
“There are a number of mobile apps that can use our expertise. There... |
| 03.06.2014 | Senseonics raised $20 million to advance continuous glucose monitoring implant | Pivotal trials have begun in Amsterdam and are scheduled for this summer in Germany and the UK and take about one year. After it secures a greenlight for its IDE application, Senseonics expects to begin clinical trials in the U.S. next year... |
| 02.04.2014 | No more needles: Startup tests implant that can measure blood sugar for up to a year | The crucial difference is that the sensors in the existing systems need to be re-calibrated several times a day and can only stay in place for a week at most. Leading vendor DexCom, for example, states that its G4 Platinum is “the only sens... |
| 20.11.2013 | Medtronic hasn’t made true artificial pancreas yet. Next 4 steps needed for this type 1 diabetes treatment | Medtronic (MDT) made a big leap toward the future of healthcare in diabetes treatment innovations when it launched what media have hailed as the first artificial pancreas, the MiniMed 530G, earlier this fall. But it’s actually just an “arti... |
| 12.11.2013 | 5BARz International, Inc. Completes $2.6M Private Placement | SEATTLE–(BUSINESS WIRE)–November 12, 2013–
5BARz International Inc. (OTCBB: BARZ) (Berlin: O5B), a technology leader in the cellular network extender industry, announced today the completion of a private placement, resulting in net proceeds... |
| 06.01.2012 | Glucose monitor gives continuous reading with needle-free technology | Instead of using needles, like other glucose monitoring systems approved by the U.S. Food and Drug Administration, Echo uses a skin preparation system that measures the electrical conductivity of the skin region where the monitoring takes p... |
| 22.08.2011 | The MassDevice Weekly Checkup: August 22, 2011 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 04.04.2011 | The MassDevice Weekly Checkup: March 4, 2011 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 08.03.2011 | The MassDevice Weekly Checkup: March 8, 2011 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 16.11.2010 | The MassDevice Weekly Checkup: November 16, 2010 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 09.11.2010 | The MassDevice Weekly Checkup: November 9, 2010 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 28.09.2010 | The MassDevice Weekly Checkup: September 28, 2010 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 22.06.2010 | The MassDevice Weekly Checkup: June 22, 2010 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 08.06.2010 | The MassDevice Weekly Checkup: June 8, 2010 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 20.05.2010 | The MassDevice Weekly Checkup: May 18, 2010 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| 11.05.2010 | The MassDevice Weekly Checkup: May 11, 2010 | Our Weekly Checkup takes the temperature of the medical device industry’s three largest U.S. clusters: Massachusetts, California and Minnesota.
The MassDevice Indices are weighted according to market capitalization, based on the number of s... |
| - | No more needles: Startup tests implant that can measure blood sugar for up to a year | Several times every day, many of the nearly 19 million Americans diagnosed with diabetes have to check their glucose levels. Even though this task can be life-saving, patients are often reluctant to do it regularly. Existing methods are eit... |
| - | Medical device patent law: Changes, subtleties and tricks-of-the-trade secrets | The patent protection landscape’s been turned on its head in the past couple years, ever since the Leahy-Smith America Invents Act went into effect. A discussion at trade group Biocom’s DeviceFest in San Diego this week addressed some of th... |
| - | Diabeto wants to add cute factor to blood-glucose monitoring for diabetes | Several companies, most notably Glooko and Dexcom have developed different approaches to de-siloing diabetics’ blood-glucose level readings from glucose meters to mobile devices to make it easier for patients and their loved ones to track t... |
| - | Dexcom, glowing from fabulous results, dismisses Medtronic as a viable CGM competitor at JPM | Dexcom CEO Kevin Sayer was positively beaming as he stood in front of a large audience gathered to hear his presentation at the annual J.P. Morgan Healthcare Conference in San Francisco on Monday.
Fresh off of pre-announcing fourth quarter ... |
| - | Dexcom will reap benefit as CMS posts criteria for Medicare coverage of CGMs | The Centers for Medicare and Medicaid Services has released guidelines on Medicare coverage for continuous glucose monitors, and one medtech company stands to make a whole lot of money from the change.
San Diego-based DexCom is the only man... |
| - | Dexcom Promotes Jereme Sylvain to Chief Financial Officer | SAN DIEGO--(BUSINESS WIRE)--Mar 23, 2021--
DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring, today announced the promotion of Jereme Sylvain to the role of Executive Vice President and Chief Financia... |
